US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

16.71

+0.31001.89%

Volume:382.08K

Turnover:6.35M

Market Cap:1.76B

PE:-11.54

High:16.89

Open:16.39

Low:16.17

Close:16.40

Loading ...

Overview Company News Filings

Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Edgewise Therapeutics (EWTX) and Avadel Pharmaceuticals (AVDL)

Edgewise Therapeutics Inc : JP Morgan Raises Target Price to $44 From $42

THOMSON REUTERS

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

Edgewise Therapeutics price target raised to $50 from $45 at Evercore ISI

Buy Rating for Edgewise Therapeutics Driven by Promising CANYON Trial Results

Edgewise Therapeutics Reports Promising Phase 2 Trial Results

Promising Outlook for Edgewise Therapeutics: Buy Rating Reaffirmed with Increased Price Target

Edgewise Therapeutics price target raised to $50 from $44 at Leerink

Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease

Edgewise Therapeutics Inc : RBC Raises Target Price to $56 From $44

THOMSON REUTERS

Edgewise Therapeutics Shares Higher on Positive Trial Results

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live

Looming Fed Rate Decision, Key Data Drive Narrow Premarket Gains for US Equity Futures

MT Newswires Live

Edgewise's Phase 2 Trial of Sevasemten to Treat Becker Muscular Dystrophy Meets Primary Endpoint; Shares Up 22% Pre-Bell

MT Newswires Live

Top Premarket Gainers

MT Newswires Live

BUZZ-Edgewise Therapeutics gains as genetic disorder drug meets mid-stage study goal

Edgewise Therapeutics Shares ‍up 8.6% Premarket After Co's Genetic Disorder Drug Meets Main Goal in Mid-Stage Study

THOMSON REUTERS

Edgewise reports CANYON Phase 2 trial of sevasemten meets primary endpoint

Edgewise Therapeutics Inc - Key Secondary Endpoint Showed Trend Towards Improvement

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EWTX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EWTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EWTX\",,,,,undefined,":{"symbol":"EWTX","market":"US","secType":"STK","nameCN":"Edgewise Therapeutics, Inc.","latestPrice":16.71,"timestamp":1746118646272,"preClose":16.4,"halted":0,"volume":382084,"delay":0,"floatShares":64123800,"shares":105140702,"eps":-1.447963,"marketStatus":"Trading","change":0.31,"latestTime":"05-01 12:57:42 EDT","open":16.39,"high":16.89,"low":16.17,"amount":6352134.273312,"amplitude":0.043902,"askPrice":16.75,"askSize":223,"bidPrice":16.65,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.447963,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":16.4,"preHourTrading":{"tag":"盘前","latestPrice":16.39,"preClose":16.4,"latestTime":"09:29 EDT","volume":358,"amount":5866.269982,"timestamp":1746106199999},"postHourTrading":{"tag":"盘后","latestPrice":16.4,"preClose":16.4,"latestTime":"19:52 EDT","volume":42400,"amount":695359.82,"timestamp":1746057144557},"volumeRatio":0.726153,"impliedVol":0.5529,"impliedVolPercentile":0.056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EWTX\",,,,,undefined,":{"symbol":"EWTX","floatShares":64123800,"roa":"-24.01%","roe":"-34.40%","lyrEps":-1.447963,"volumeRatio":0.726153,"shares":105140702,"dividePrice":0,"high":16.89,"amplitude":0.043902,"preClose":16.4,"low":16.17,"week52Low":10.6,"pbRate":"3.83","week52High":38.12,"institutionHeld":0,"latestPrice":16.71,"committee":-0.380805,"eps":-1.447963,"divideRate":0,"volume":382084,"delay":0,"ttmEps":-1.447963,"open":16.39,"prevYearClose":26.7,"prevWeekClose":14.84,"prevMonthClose":16.4,"prevQuarterClose":22,"fiveDayClose":15.4,"twentyDayClose":15.52,"sixtyDayClose":29.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EWTX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503309371","title":"Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309371?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA78BJZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","EWTX","BK4007"],"gpt_icon":0},{"id":"2503340421","title":"Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Edgewise Therapeutics (EWTX) and Avadel Pharmaceuticals (AVDL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503340421","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503340421?lang=en_us&edition=fundamental","pubTime":"2025-01-13 14:00","pubTimestamp":1736748019,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vir Biotechnology (VIR – Research Report), Edgewise ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vir-biotechnology-vir-edgewise-therapeutics-ewtx-and-avadel-pharmaceuticals-avdl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vir-biotechnology-vir-edgewise-therapeutics-ewtx-and-avadel-pharmaceuticals-avdl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","VIR","BK4568","AVDL","BK4539","BK4139","EWTX","BK4007","BK4535","BK4137","HCSG"],"gpt_icon":0},{"id":"2492143530","title":"Edgewise Therapeutics Inc : JP Morgan Raises Target Price to $44 From $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2492143530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492143530?lang=en_us&edition=fundamental","pubTime":"2024-12-19 16:18","pubTimestamp":1734596280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NK045:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","EWTX"],"gpt_icon":0},{"id":"2492961333","title":"EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2492961333","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492961333?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:18","pubTimestamp":1734445080,"startTime":"0","endTime":"0","summary":"Shares of Edgewise Therapeutics EWTX were up more than 18% on Monday after it announced positive results from the mid-stage CANYON study on its lead pipeline drug, sevasemten, in patients with a rare genetic disorder called Becker Muscular Dystrophy .The study met its primary endpoint of change from baseline in creatine kinase , a biomarker associated with skeletal muscle damage. Data from the study showed a significant reduction in CK levels in the sevasemten-treated group, with an average decrease of 28% compared to placebo between six and 12 months. The drug was also well-tolerated by study participants.Edgewise remains on schedule to complete recruitment for a pivotal cohort of the CANYON study, called GRAND CANYON, which is expected to be achieved in the first quarter of 2025. If data from this cohort is also positive, management intends to start discussions with the FDA and EMA for seeking approval for sevasemten in the BMD indication.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ewtx-stock-rises-upbeat-data-141800266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4139","CTMX","BK4531","HCM","CSTL","BK4585","SPRO","BK4588","EWTX","BK4196","BK4007"],"gpt_icon":0},{"id":"2492095085","title":"Edgewise Therapeutics price target raised to $50 from $45 at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2492095085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492095085?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:50","pubTimestamp":1734443450,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Cory Kasimov raised the firm’s price target on Edgewise Therapeutics (EWTX) to $50 from $45 and keeps an Outperform rating on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-price-target-raised-to-50-from-45-at-evercore-isi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-price-target-raised-to-50-from-45-at-evercore-isi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2492558679","title":"Buy Rating for Edgewise Therapeutics Driven by Promising CANYON Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2492558679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492558679?lang=en_us&edition=fundamental","pubTime":"2024-12-17 08:58","pubTimestamp":1734397135,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Tessa Romero has maintained their bullish stance on EWTX stock, giving a Buy rating yesterday. Tessa Romero’s rating is based o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-edgewise-therapeutics-driven-by-promising-canyon-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-edgewise-therapeutics-driven-by-promising-canyon-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2492062178","title":"Edgewise Therapeutics Reports Promising Phase 2 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2492062178","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492062178?lang=en_us&edition=fundamental","pubTime":"2024-12-17 06:48","pubTimestamp":1734389319,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics ( ($EWTX) ) has provided an announcement. Edgewise Therapeutics announced positive topline results from their Phase 2 CANYON ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/edgewise-therapeutics-reports-promising-phase-2-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/edgewise-therapeutics-reports-promising-phase-2-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","EWTX","BK4007"],"gpt_icon":0},{"id":"2492640233","title":"Promising Outlook for Edgewise Therapeutics: Buy Rating Reaffirmed with Increased Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2492640233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492640233?lang=en_us&edition=fundamental","pubTime":"2024-12-17 04:55","pubTimestamp":1734382512,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Joseph Schwartz reiterated a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-edgewise-therapeutics-buy-rating-reaffirmed-with-increased-price-target?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-edgewise-therapeutics-buy-rating-reaffirmed-with-increased-price-target?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2492471386","title":"Edgewise Therapeutics price target raised to $50 from $44 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2492471386","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492471386?lang=en_us&edition=fundamental","pubTime":"2024-12-17 04:50","pubTimestamp":1734382208,"startTime":"0","endTime":"0","summary":"Leerink raised the firm’s price target on Edgewise Therapeutics (EWTX) to $50 from $44 and keeps an Outperform rating on the shares after the compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-price-target-raised-to-50-from-44-at-leerink?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-price-target-raised-to-50-from-44-at-leerink?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2492614251","title":"Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2492614251","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492614251?lang=en_us&edition=fundamental","pubTime":"2024-12-17 00:56","pubTimestamp":1734368184,"startTime":"0","endTime":"0","summary":"On Monday, Edgewise Therapeutics, Inc., revealed topline results from the Phase 2 CANYON trial of sevasemten in individuals with Becker muscular dystrophy , isa genetic disorder that causes progressive muscle weakness.Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor designed to protect muscle against contraction-induced damage in muscular dystrophies.Also Read: Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment. The company adds that CANYON is the largest interventional trial to date in BMD and the first to achieve its primary endpoint. The trial was conducted among 40 adults and 29 adolescents.The trial met its primary endpoint of change from baseline in creatine kinase.The results demonstrated a significant change from baseline in CK in the sevasemten-treated group .North Star Ambulatory Assessment, the key secondary endpoint of function, showed a trend towards improvement over time in the sevasemten-tr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/JtMJqqV01ML0g6i4.TdV2g--~B/aD01Mzg7dz05NTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/146a4ab97e806d7f24cf345f0de503c4","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/JtMJqqV01ML0g6i4.TdV2g--~B/aD01Mzg7dz05NTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/146a4ab97e806d7f24cf345f0de503c4"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/edgewise-therapeutics-lead-candidate-reduces-165624618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SSI","BK4139","LENZ","BK4007","EWTX","BK4539"],"gpt_icon":0},{"id":"2492619120","title":"Edgewise Therapeutics Inc : RBC Raises Target Price to $56 From $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2492619120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492619120?lang=en_us&edition=fundamental","pubTime":"2024-12-17 00:33","pubTimestamp":1734366824,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH1BB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EWTX","BK4539"],"gpt_icon":0},{"id":"2491692522","title":"Edgewise Therapeutics Shares Higher on Positive Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692522","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491692522?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:38","pubTimestamp":1734359880,"startTime":"0","endTime":"0","summary":"Shares of Edgewise Therapeutics advanced after the company reported positive results for its latest trial of sevasemten in patients with Becker muscular dystrophy.The stock rose 5.4% to $29.11 early in the session. Shares have more than doubled since the start of the year.The biopharmaceutical company said before the bell that the Phase 2 trial of its sevasemten treatment met its primary endpoint in reducing levels of creatine kinase, a marker of skeletal muscle damage.Patients treated with sevasemten also showed stabilization in an assessment tied to the trial's secondary endpoint, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2491069192","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2491069192","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491069192?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:13","pubTimestamp":1734358390,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Monday as the Health Care Select Sector SPDR Fund  was up 0.1% and the iShares Biotechnology ETF  was down 0.4%.Edgewise Therapeutics  shares soared 14% after it said a phase 2 trial of sevasemten to treat patients with Becker muscular dystrophy met its primary endpoint of change from baseline in creatine kinase.PureTech Health  shares jumped 13% after it said that a phase 2 clinical trial of its drug deupirfenidone as a treatment of patients with idiopathic pulmonary fibrosis reached its primary endpoint.Foghorn Therapeutics  shares fell 17% after it said it has decided to discontinue the independent development of FHD-286 in combination with decitabine to treat patients with relapsed and/or refractory acute myeloid leukemia.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4007","FHTX","BK4588","BK4539","BK4139","IBB","XLV","PRTC","BK4581","EWTX"],"gpt_icon":0},{"id":"2491990726","title":"Looming Fed Rate Decision, Key Data Drive Narrow Premarket Gains for US Equity Futures","url":"https://stock-news.laohu8.com/highlight/detail?id=2491990726","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491990726?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:59","pubTimestamp":1734357540,"startTime":"0","endTime":"0","summary":"US equity futures were modestly higher pre-bell Monday as traders looked ahead to the Federal Reserve's interest rate decision and key economic data later in the week.Dow Jones Industrial Average futu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4550","HON","USAW.SI","US5Y.BOND","DDM","SDOW","US3Y.BOND","TQQQ","MNQmain","US10Y.BOND","IE0034235188.USD","EQR","LU0787776722.HKD","BK4534","NQmain","BK4206","BK4529","BK4512",".DJI","IE00B1BXHZ80.USD","USJW.SI","QID","BK4602","LU1548497426.USD","LU1720051108.HKD",".IXIC","UDOW","DOG","LU0348723411.USD","QLD","BK4588","TSYW.SI","PSQ","NVIW.SI","US30Y.BOND","LU0683600562.USD","LU2357305700.SGD","EWTX","US7Y.BOND","US2Y.BOND","LU2087625088.SGD","DXD","US6M.BOND","DJX","SQQQ","US12M.BOND","MCHP",".SPX"],"gpt_icon":1},{"id":"2491169383","title":"Edgewise's Phase 2 Trial of Sevasemten to Treat Becker Muscular Dystrophy Meets Primary Endpoint; Shares Up 22% Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2491169383","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491169383?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:55","pubTimestamp":1734353729,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics  said Monday that a phase 2 trial of sevasemten to treat patients with Becker muscular dystrophy met its primary endpoint of change from baseline in creatine kinase.The biopharmaceutical company also said the key secondary endpoint of function demonstrated an improving trend over time in the sevasemten-treated group. It added the drug was well-tolerated, with no new safety concerns in adult or adolescent patients.Shares of Edgewise Therapeutics were up 22% in recent premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4007","EWTX"],"gpt_icon":0},{"id":"2491698060","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2491698060","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491698060?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:53","pubTimestamp":1734353637,"startTime":"0","endTime":"0","summary":"Sidus Space  shares soared 65% pre-bell Monday, adding to Friday's gains.U-BX Technology  shares surged 23% following a muted session.Empire Petroleum  shares rose 28% after closing nearly unchanged on Friday.Edgewise Therapeutics  shares increased 22% after the company said its phase 2 trial of a treatment candidate for Becker muscular dystrophy met its primary endpoint.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","UBXG","BK4007","EWTX","BK4213","BK4187","EP","BK4134","SIDU"],"gpt_icon":0},{"id":"2491166486","title":"BUZZ-Edgewise Therapeutics gains as genetic disorder drug meets mid-stage study goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2491166486","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491166486?lang=en_us&edition=fundamental","pubTime":"2024-12-16 19:41","pubTimestamp":1734349299,"startTime":"0","endTime":"0","summary":"BUZZ-Edgewise Therapeutics gains as genetic disorder drug meets mid-stage study goal** Shares of Edgewise Therapeutics rise about 17% to $32.28 in premarket trading ** Company says its experimental genetic disorder drug met the main goal in a mid-stage study** The drug, sevasemten, is being developed to treat Becker Muscular Dystrophy, a rare condition that results in progressive muscle weakness and degeneration   ** Sevasemten helped significantly reduce levels of creatine kinase, an enzyme associated with skeletal muscle damage in the study- EWTX** Up to last close, stock more than doubled YTD   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4N3NH0SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","EWTX","BK4007"],"gpt_icon":0},{"id":"2491669949","title":"Edgewise Therapeutics Shares ‍up 8.6% Premarket After Co's Genetic Disorder Drug Meets Main Goal in Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2491669949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491669949?lang=en_us&edition=fundamental","pubTime":"2024-12-16 19:16","pubTimestamp":1734347799,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4N3NH0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","EWTX","BK4007"],"gpt_icon":0},{"id":"2491669951","title":"Edgewise reports CANYON Phase 2 trial of sevasemten meets primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2491669951","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491669951?lang=en_us&edition=fundamental","pubTime":"2024-12-16 19:05","pubTimestamp":1734347106,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics (EWTX) announced topline results from the Phase 2 CANYON trial of sevasemten in individuals with Becker muscular dystrophy. S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/edgewise-reports-canyon-phase-2-trial-of-sevasemten-meets-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/edgewise-reports-canyon-phase-2-trial-of-sevasemten-meets-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWTX","BK4007","BK4539"],"gpt_icon":0},{"id":"2491666480","title":"Edgewise Therapeutics Inc - Key Secondary Endpoint Showed Trend Towards Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2491666480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491666480?lang=en_us&edition=fundamental","pubTime":"2024-12-16 19:00","pubTimestamp":1734346800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA9RCC0Q:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EWTX","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":108,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EWTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-03","symbol":"EWTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2024-11-07","symbol":"EWTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2024-08-08","symbol":"EWTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-05-09","symbol":"EWTX","fiscalQuarterEnding":"2024/03","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-02-22","symbol":"EWTX","fiscalQuarterEnding":"2023/12","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"pre","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EWTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EWTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.5,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EWTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EWTX","date":"2025-04-29","current":-12.320225,"percent":0.529353,"low":-97.877011,"twenty":-25.649142,"median":-14.178715,"eighty":-7.564848,"high":-3.909806,"avg":-18.994121,"sd":17.091429,"marketCap":1648606207},"quantilePoints":[{"date":"2021-03-26","current":-81.586839,"twenty":-66.357296,"median":-43.512981,"eighty":-43.512981,"marketCap":1397011440},{"date":"2021-04-01","current":-84.505847,"twenty":-90.796619,"median":-84.505847,"eighty":-51.127753,"marketCap":1446993610},{"date":"2021-04-09","current":-83.182363,"twenty":-87.366824,"median":-84.477687,"eighty":-81.905944,"marketCap":1424331597},{"date":"2021-04-16","current":-76.255192,"twenty":-85.046504,"median":-83.182363,"eighty":-78.502298,"marketCap":1305717659},{"date":"2021-04-23","current":-77.550517,"twenty":-84.500215,"median":-79.915892,"eighty":-76.074974,"marketCap":1327897501},{"date":"2021-04-30","current":-80.648032,"twenty":-84.477687,"median":-79.26823,"eighty":-75.692008,"marketCap":1380936254},{"date":"2021-05-07","current":-82.337586,"twenty":-84.24115,"median":-80.605793,"eighty":-76.074974,"marketCap":1409866483},{"date":"2021-05-14","current":-65.742033,"twenty":-83.272473,"median":-79.26823,"eighty":-75.24146,"marketCap":1364344414},{"date":"2021-05-21","current":-66.833778,"twenty":-83.075358,"median":-78.437533,"eighty":-68.470572,"marketCap":1387001397},{"date":"2021-05-28","current":-68.518863,"twenty":-82.619178,"median":-77.550517,"eighty":-67.62648,"marketCap":1421971958},{"date":"2021-06-04","current":-62.537999,"twenty":-82.506541,"median":-76.029919,"eighty":-66.833778,"marketCap":1297851094},{"date":"2021-06-11","current":-61.493721,"twenty":-82.337586,"median":-75.480813,"eighty":-65.433497,"marketCap":1276179198},{"date":"2021-06-18","current":-62.632933,"twenty":-81.586839,"median":-74.481161,"eighty":-63.677211,"marketCap":1299821267},{"date":"2021-06-25","current":-56.841938,"twenty":-81.549127,"median":-71.115632,"eighty":-62.632933,"marketCap":1179640748},{"date":"2021-07-02","current":-48.440249,"twenty":-81.520968,"median":-68.376461,"eighty":-61.992127,"marketCap":1005280487},{"date":"2021-07-09","current":-55.845128,"twenty":-80.822619,"median":-67.830589,"eighty":-60.515897,"marketCap":1158953937},{"date":"2021-07-16","current":-46.897566,"twenty":-80.58045,"median":-67.059247,"eighty":-57.131488,"marketCap":973265185},{"date":"2021-07-23","current":-47.751975,"twenty":-80.270698,"median":-65.979369,"eighty":-55.788167,"marketCap":990996737},{"date":"2021-07-30","current":-41.557509,"twenty":-79.454081,"median":-65.113093,"eighty":-51.900606,"marketCap":862442985},{"date":"2021-08-06","current":-43.171393,"twenty":-78.727572,"median":-63.843346,"eighty":-49.973439,"marketCap":895935917},{"date":"2021-08-13","current":-29.500591,"twenty":-78.502298,"median":-63.617877,"eighty":-48.459236,"marketCap":801000038},{"date":"2021-08-20","current":-26.144127,"twenty":-78.412189,"median":-62.632933,"eighty":-46.878579,"marketCap":709865347},{"date":"2021-08-27","current":-27.559285,"twenty":-78.350239,"median":-62.288797,"eighty":-43.512981,"marketCap":748289704},{"date":"2021-09-03","current":-30.244456,"twenty":-77.708209,"median":-61.778524,"eighty":-42.335971,"marketCap":821197456},{"date":"2021-09-10","current":-29.228445,"twenty":-76.773322,"median":-60.568111,"eighty":-37.118848,"marketCap":793610739},{"date":"2021-09-17","current":-31.387467,"twenty":-76.120028,"median":-59.547567,"eighty":-30.96292,"marketCap":852232513},{"date":"2021-09-24","current":-33.002198,"twenty":-75.945441,"median":-56.865672,"eighty":-31.216923,"marketCap":896075689},{"date":"2021-10-01","current":-31.8229,"twenty":-75.720167,"median":-56.165532,"eighty":-31.028235,"marketCap":864055392},{"date":"2021-10-08","current":-33.201772,"twenty":-75.45547,"median":-52.783495,"eighty":-31.216923,"marketCap":901494508},{"date":"2021-10-15","current":-32.185761,"twenty":-75.269619,"median":-51.644284,"eighty":-31.216923,"marketCap":873907791},{"date":"2021-10-22","current":-30.298885,"twenty":-74.774017,"median":-50.623739,"eighty":-30.843176,"marketCap":822675316},{"date":"2021-10-29","current":-29.936024,"twenty":-74.261519,"median":-49.615061,"eighty":-30.429515,"marketCap":812822917},{"date":"2021-11-05","current":-36.104659,"twenty":-73.574434,"median":-48.463983,"eighty":-30.585545,"marketCap":980313700},{"date":"2021-11-12","current":-25.973644,"twenty":-70.695959,"median":-47.835043,"eighty":-30.3642,"marketCap":946973086},{"date":"2021-11-19","current":-26.960669,"twenty":-68.718225,"median":-46.802632,"eighty":-30.139226,"marketCap":982959049},{"date":"2021-11-26","current":-27.555589,"twenty":-68.461902,"median":-46.090624,"eighty":-29.925138,"marketCap":1004649219},{"date":"2021-12-03","current":-20.281346,"twenty":-68.243553,"median":-43.342187,"eighty":-29.489705,"marketCap":739437600},{"date":"2021-12-10","current":-26.636168,"twenty":-67.95875,"median":-42.530586,"eighty":-29.16313,"marketCap":971128048},{"date":"2021-12-17","current":-20.957391,"twenty":-67.707174,"median":-40.869235,"eighty":-28.930899,"marketCap":764085520},{"date":"2021-12-23","current":-21.673999,"twenty":-67.474585,"median":-36.64895,"eighty":-28.749469,"marketCap":790212315},{"date":"2021-12-31","current":-20.659931,"twenty":-67.194528,"median":-36.104659,"eighty":-28.152808,"marketCap":753240435},{"date":"2022-01-07","current":-23.729175,"twenty":-66.724604,"median":-34.635072,"eighty":-27.556328,"marketCap":865141992},{"date":"2022-01-14","current":-23.661571,"twenty":-66.226199,"median":-33.419488,"eighty":-27.258434,"marketCap":862677200},{"date":"2022-01-21","current":-19.726989,"twenty":-65.979369,"median":-33.002198,"eighty":-26.866023,"marketCap":719226305},{"date":"2022-01-28","current":-17.036331,"twenty":-65.742033,"median":-32.793554,"eighty":-26.487438,"marketCap":621127584},{"date":"2022-02-04","current":-16.333244,"twenty":-65.433497,"median":-32.566765,"eighty":-25.973644,"marketCap":595493747},{"date":"2022-02-11","current":-16.292681,"twenty":-64.79269,"median":-32.140404,"eighty":-25.649142,"marketCap":594014872},{"date":"2022-02-18","current":-15.724804,"twenty":-64.080682,"median":-31.8229,"eighty":-24.567471,"marketCap":573310619},{"date":"2022-02-25","current":-15.034113,"twenty":-63.890813,"median":-31.568898,"eighty":-23.715654,"marketCap":643655467},{"date":"2022-03-04","current":-12.108243,"twenty":-63.805372,"median":-31.432825,"eighty":-23.13696,"marketCap":518390210},{"date":"2022-03-11","current":-12.975596,"twenty":-63.700945,"median":-31.260466,"eighty":-21.530677,"marketCap":555524179},{"date":"2022-03-18","current":-13.160631,"twenty":-63.582277,"median":-30.997392,"eighty":-20.824886,"marketCap":563446093},{"date":"2022-03-25","current":-10.732044,"twenty":-63.349688,"median":-30.843176,"eighty":-20.48416,"marketCap":459470979},{"date":"2022-04-01","current":-11.217761,"twenty":-62.765841,"median":-30.425886,"eighty":-20.1867,"marketCap":480266002},{"date":"2022-04-08","current":-10.651091,"twenty":-62.556986,"median":-30.298885,"eighty":-19.372742,"marketCap":456005142},{"date":"2022-04-14","current":-10.08442,"twenty":-62.409838,"median":-30.244456,"eighty":-18.585826,"marketCap":431744282},{"date":"2022-04-22","current":-9.679656,"twenty":-62.281676,"median":-30.026739,"eighty":-17.801614,"marketCap":414415096},{"date":"2022-04-29","current":-9.228632,"twenty":-62.096555,"median":-29.73645,"eighty":-17.052556,"marketCap":395105432},{"date":"2022-05-06","current":-8.823646,"twenty":-61.863965,"median":-29.49152,"eighty":-16.322427,"marketCap":377766750},{"date":"2022-05-13","current":-7.662712,"twenty":-61.607642,"median":-29.272743,"eighty":-15.654495,"marketCap":388177644},{"date":"2022-05-20","current":-7.124462,"twenty":-60.938355,"median":-29.092372,"eighty":-13.819819,"marketCap":360911015},{"date":"2022-05-27","current":-5.940314,"twenty":-60.41147,"median":-29.028872,"eighty":-13.375735,"marketCap":300924432},{"date":"2022-06-03","current":-5.979459,"twenty":-60.098186,"median":-28.829298,"eighty":-12.9941,"marketCap":302907459},{"date":"2022-06-10","current":-5.832664,"twenty":-59.595034,"median":-28.532432,"eighty":-12.526885,"marketCap":295471106},{"date":"2022-06-17","current":-6.48835,"twenty":-58.465315,"median":-28.204592,"eighty":-12.02729,"marketCap":328686818},{"date":"2022-06-24","current":-8.347756,"twenty":-57.131488,"median":-28.042341,"eighty":-11.386606,"marketCap":422880627},{"date":"2022-07-01","current":-7.90737,"twenty":-56.860925,"median":-27.557437,"eighty":-11.217761,"marketCap":400571567},{"date":"2022-07-08","current":-10.001649,"twenty":-56.841938,"median":-27.486713,"eighty":-10.859255,"marketCap":506663541},{"date":"2022-07-15","current":-9.942931,"twenty":-56.485935,"median":-27.214567,"eighty":-10.523879,"marketCap":503689000},{"date":"2022-07-22","current":-9.610195,"twenty":-55.845128,"median":-26.913346,"eighty":-10.040795,"marketCap":486833265},{"date":"2022-07-29","current":-9.4634,"twenty":-55.560325,"median":-26.582084,"eighty":-10.001649,"marketCap":479396912},{"date":"2022-08-05","current":-9.425986,"twenty":-52.783495,"median":-26.426594,"eighty":-9.874427,"marketCap":531361699},{"date":"2022-08-12","current":-9.302309,"twenty":-52.688561,"median":-26.144127,"eighty":-9.818432,"marketCap":524389756},{"date":"2022-08-19","current":-9.682175,"twenty":-52.071488,"median":-25.796329,"eighty":-9.691009,"marketCap":545803583},{"date":"2022-08-26","current":-8.666254,"twenty":-51.217079,"median":-25.649142,"eighty":-9.668913,"marketCap":488534046},{"date":"2022-09-02","current":-9.514327,"twenty":-51.098411,"median":-24.817607,"eighty":-9.585,"marketCap":536341659},{"date":"2022-09-09","current":-10.971954,"twenty":-50.718673,"median":-24.520148,"eighty":-9.576166,"marketCap":618510994},{"date":"2022-09-16","current":-10.732288,"twenty":-50.111093,"median":-23.729175,"eighty":-9.576166,"marketCap":605000547},{"date":"2022-09-23","current":-10.228162,"twenty":-49.944958,"median":-23.573684,"eighty":-9.596582,"marketCap":576581941},{"date":"2022-09-30","current":-11.023561,"twenty":-49.422819,"median":-22.336523,"eighty":-9.608052,"marketCap":621420186},{"date":"2022-10-07","current":-11.157995,"twenty":-48.782012,"median":-21.775405,"eighty":-9.638677,"marketCap":628998481},{"date":"2022-10-14","current":-11.673324,"twenty":-48.501957,"median":-20.94387,"eighty":-9.66429,"marketCap":658048612},{"date":"2022-10-21","current":-11.561296,"twenty":-48.444996,"median":-20.808661,"eighty":-9.677507,"marketCap":651733366},{"date":"2022-10-28","current":-10.575449,"twenty":-48.022538,"median":-20.659931,"eighty":-9.681671,"marketCap":596159203},{"date":"2022-11-04","current":-9.930135,"twenty":-47.785202,"median":-20.382753,"eighty":-9.689242,"marketCap":604953750},{"date":"2022-11-11","current":-11.123411,"twenty":-47.068448,"median":-20.227263,"eighty":-9.720307,"marketCap":677649341},{"date":"2022-11-18","current":-10.376317,"twenty":-46.821619,"median":-19.693187,"eighty":-9.73367,"marketCap":632135580},{"date":"2022-11-25","current":-10.189543,"twenty":-46.503588,"median":-19.206435,"eighty":-9.746315,"marketCap":620757139},{"date":"2022-12-02","current":-9.193416,"twenty":-46.176065,"median":-18.618276,"eighty":-9.687475,"marketCap":560072123},{"date":"2022-12-09","current":-8.083151,"twenty":-44.544038,"median":-18.212649,"eighty":-9.631556,"marketCap":492433616},{"date":"2022-12-16","current":-8.238795,"twenty":-43.512981,"median":-17.752938,"eighty":-9.530229,"marketCap":501915650},{"date":"2022-12-23","current":-8.871751,"twenty":-43.308028,"median":-17.124217,"eighty":-9.483355,"marketCap":540475920},{"date":"2022-12-30","current":-9.276427,"twenty":-43.038485,"median":-17.02281,"eighty":-9.41096,"marketCap":565129208},{"date":"2023-01-06","current":-9.77449,"twenty":-42.777416,"median":-16.617183,"eighty":-9.405952,"marketCap":595471716},{"date":"2023-01-13","current":-11.46583,"twenty":-42.335971,"median":-16.292681,"eighty":-9.403018,"marketCap":698509815},{"date":"2023-01-20","current":-11.26868,"twenty":-41.557509,"median":-15.724804,"eighty":-9.411319,"marketCap":686499239},{"date":"2023-01-27","current":-11.320561,"twenty":-41.391374,"median":-15.278052,"eighty":-9.425986,"marketCap":689659917},{"date":"2023-02-03","current":-11.15454,"twenty":-40.347096,"median":-13.681043,"eighty":-9.443654,"marketCap":679545748},{"date":"2023-02-10","current":-10.303682,"twenty":-36.866667,"median":-13.524919,"eighty":-9.4634,"marketCap":627710630},{"date":"2023-02-17","current":-11.081906,"twenty":-36.431234,"median":-13.021855,"eighty":-9.496659,"marketCap":675120799},{"date":"2023-02-24","current":-8.941294,"twenty":-36.213517,"median":-12.975596,"eighty":-9.459451,"marketCap":604789155},{"date":"2023-03-03","current":-8.819708,"twenty":-36.115545,"median":-12.657566,"eighty":-9.396549,"marketCap":596565035},{"date":"2023-03-10","current":-6.930438,"twenty":-35.640197,"median":-12.432055,"eighty":-9.301529,"marketCap":468774858},{"date":"2023-03-17","current":-7.080084,"twenty":-35.088648,"median":-12.085114,"eighty":-9.286734,"marketCap":478896852},{"date":"2023-03-24","current":-6.425386,"twenty":-34.428241,"median":-11.99671,"eighty":-9.263326,"marketCap":434613127},{"date":"2023-03-31","current":-6.23833,"twenty":-33.782349,"median":-11.981401,"eighty":-9.190459,"marketCap":421960634},{"date":"2023-04-06","current":-5.901628,"twenty":-33.513832,"median":-11.88644,"eighty":-9.139459,"marketCap":399186147},{"date":"2023-04-14","current":-5.686514,"twenty":-33.288858,"median":-11.673324,"eighty":-9.025207,"marketCap":384635781},{"date":"2023-04-21","current":-6.509562,"twenty":-33.082028,"median":-11.513563,"eighty":-8.968257,"marketCap":440306749},{"date":"2023-04-28","current":-7.725428,"twenty":-32.925997,"median":-11.414361,"eighty":-8.904016,"marketCap":522547952},{"date":"2023-05-05","current":-8.91534,"twenty":-32.864311,"median":-11.39589,"eighty":-8.886264,"marketCap":603033631},{"date":"2023-05-12","current":-7.941181,"twenty":-32.780853,"median":-11.356537,"eighty":-8.86345,"marketCap":602084470},{"date":"2023-05-19","current":-7.770335,"twenty":-32.664738,"median":-11.335505,"eighty":-8.819805,"marketCap":589131223},{"date":"2023-05-26","current":-8.087491,"twenty":-32.588537,"median":-11.314834,"eighty":-8.738985,"marketCap":613177395},{"date":"2023-06-02","current":-8.337878,"twenty":-32.45065,"median":-11.26868,"eighty":-8.673321,"marketCap":632161215},{"date":"2023-06-09","current":-8.588264,"twenty":-32.240191,"median":-11.217761,"eighty":-8.606166,"marketCap":651145036},{"date":"2023-06-16","current":-7.277907,"twenty":-32.149475,"median":-11.175293,"eighty":-8.472226,"marketCap":551796376},{"date":"2023-06-23","current":-6.535093,"twenty":-32.066017,"median":-11.15454,"eighty":-8.398151,"marketCap":495477709},{"date":"2023-06-30","current":-6.284707,"twenty":-31.949902,"median":-11.133788,"eighty":-8.367329,"marketCap":476493889},{"date":"2023-07-07","current":-6.201244,"twenty":-31.8483,"median":-11.101981,"eighty":-8.326363,"marketCap":470165949},{"date":"2023-07-14","current":-6.234629,"twenty":-31.648727,"median":-11.056151,"eighty":-8.237132,"marketCap":472697125},{"date":"2023-07-21","current":-6.126128,"twenty":-31.576155,"median":-11.009596,"eighty":-8.157599,"marketCap":464470803},{"date":"2023-07-28","current":-5.541893,"twenty":-31.525355,"median":-10.936142,"eighty":-8.089649,"marketCap":420175222},{"date":"2023-08-04","current":-5.466777,"twenty":-31.48544,"median":-10.895132,"eighty":-8.08345,"marketCap":414480076},{"date":"2023-08-11","current":-5.266138,"twenty":-31.40561,"median":-10.872006,"eighty":-7.990486,"marketCap":427715749},{"date":"2023-08-18","current":-5.531789,"twenty":-31.387467,"median":-10.754694,"eighty":-7.915178,"marketCap":449291914},{"date":"2023-08-25","current":-5.594295,"twenty":-31.285866,"median":-10.720479,"eighty":-7.832047,"marketCap":454368659},{"date":"2023-09-01","current":-4.883288,"twenty":-31.202408,"median":-10.67723,"eighty":-7.750255,"marketCap":396620687},{"date":"2023-09-08","current":-5.070807,"twenty":-31.166122,"median":-10.653868,"eighty":-7.689118,"marketCap":411850921},{"date":"2023-09-15","current":-5.258325,"twenty":-30.966549,"median":-10.644383,"eighty":-7.550131,"marketCap":427081156},{"date":"2023-09-22","current":-4.805156,"twenty":-30.843176,"median":-10.614972,"eighty":-7.297405,"marketCap":390274756},{"date":"2023-09-29","current":-4.602011,"twenty":-30.843176,"median":-10.575449,"eighty":-7.217805,"marketCap":373775335},{"date":"2023-10-06","current":-5.281765,"twenty":-30.745204,"median":-10.523879,"eighty":-7.131289,"marketCap":428984935},{"date":"2023-10-13","current":-5.188006,"twenty":-30.538373,"median":-10.47175,"eighty":-7.094968,"marketCap":421369818},{"date":"2023-10-20","current":-5.75056,"twenty":-30.422257,"median":-10.386693,"eighty":-6.924854,"marketCap":467060521},{"date":"2023-10-27","current":-4.906728,"twenty":-30.407743,"median":-10.376317,"eighty":-6.918949,"marketCap":398524466},{"date":"2023-11-03","current":-5.133313,"twenty":-30.300331,"median":-10.36594,"eighty":-6.651941,"marketCap":416927666},{"date":"2023-11-10","current":-4.058671,"twenty":-30.298885,"median":-10.345188,"eighty":-6.535093,"marketCap":362987253},{"date":"2023-11-17","current":-4.505856,"twenty":-30.262599,"median":-10.305132,"eighty":-6.490856,"marketCap":402981210},{"date":"2023-11-24","current":-4.591006,"twenty":-30.248085,"median":-10.231048,"eighty":-6.415933,"marketCap":410596603},{"date":"2023-12-01","current":-4.314268,"twenty":-30.171883,"median":-10.189543,"eighty":-6.33747,"marketCap":385846576},{"date":"2023-12-08","current":-4.874839,"twenty":-30.124711,"median":-10.137891,"eighty":-6.293053,"marketCap":435981246},{"date":"2023-12-15","current":-5.130289,"twenty":-29.97231,"median":-10.099513,"eighty":-6.23833,"marketCap":458827425},{"date":"2023-12-22","current":-6.521073,"twenty":-29.92151,"median":-10.072394,"eighty":-6.233499,"marketCap":583212177},{"date":"2023-12-29","current":-8.160211,"twenty":-29.845309,"median":-10.040795,"eighty":-6.236109,"marketCap":729808492},{"date":"2024-01-05","current":-7.223561,"twenty":-29.73645,"median":-10.025941,"eighty":-6.23833,"marketCap":646039169},{"date":"2024-01-12","current":-6.563648,"twenty":-29.718307,"median":-10.001649,"eighty":-6.23833,"marketCap":587019874},{"date":"2024-01-19","current":-7.633397,"twenty":-29.544134,"median":-9.980338,"eighty":-6.242047,"marketCap":682692883},{"date":"2024-01-26","current":-14.999174,"twenty":-29.486077,"median":-10.002878,"eighty":-6.276361,"marketCap":1341451096},{"date":"2024-02-02","current":-18.288884,"twenty":-29.409875,"median":-10.035539,"eighty":-6.291384,"marketCap":1635666372},{"date":"2024-02-09","current":-18.889614,"twenty":-29.296541,"median":-10.072394,"eighty":-6.293053,"marketCap":1689392639},{"date":"2024-02-16","current":-17.468841,"twenty":-29.237305,"median":-10.099513,"eighty":-6.306407,"marketCap":1562325752},{"date":"2024-02-23","current":-16.146996,"twenty":-29.16313,"median":-10.127337,"eighty":-6.311215,"marketCap":1617331521},{"date":"2024-03-01","current":-15.180221,"twenty":-29.08693,"median":-10.175244,"eighty":-6.318381,"marketCap":1520496473},{"date":"2024-03-08","current":-16.490944,"twenty":-29.043386,"median":-10.231048,"eighty":-6.333729,"marketCap":1651782452},{"date":"2024-03-15","current":-15.868118,"twenty":-29.028872,"median":-10.305132,"eighty":-6.342362,"marketCap":1589398334},{"date":"2024-03-22","current":-15.700792,"twenty":-28.930899,"median":-10.345188,"eighty":-6.373177,"marketCap":1572638422},{"date":"2024-03-28","current":-16.695454,"twenty":-28.85107,"median":-10.36594,"eighty":-6.398597,"marketCap":1672266789},{"date":"2024-04-05","current":-15.356843,"twenty":-28.814784,"median":-10.376317,"eighty":-6.411307,"marketCap":1538187491},{"date":"2024-04-12","current":-15.328956,"twenty":-28.77124,"median":-10.417822,"eighty":-6.421102,"marketCap":1535394173},{"date":"2024-04-19","current":-14.408433,"twenty":-28.573662,"median":-10.482953,"eighty":-6.450572,"marketCap":1443191854},{"date":"2024-04-26","current":-14.865399,"twenty":-28.302514,"median":-10.530638,"eighty":-6.489352,"marketCap":1488962987},{"date":"2024-05-03","current":-17.989558,"twenty":-28.241955,"median":-10.579646,"eighty":-6.494428,"marketCap":1801888082},{"date":"2024-05-10","current":-17.647382,"twenty":-28.1787,"median":-10.631463,"eighty":-6.503696,"marketCap":1867975340},{"date":"2024-05-17","current":-16.04147,"twenty":-28.100854,"median":-10.648596,"eighty":-6.512821,"marketCap":1697989584},{"date":"2024-05-24","current":-15.273809,"twenty":-27.885499,"median":-10.653926,"eighty":-6.519055,"marketCap":1616732656},{"date":"2024-05-31","current":-15.441459,"twenty":-27.632045,"median":-10.687606,"eighty":-6.522512,"marketCap":1634478422},{"date":"2024-06-07","current":-15.538519,"twenty":-27.558546,"median":-10.732166,"eighty":-6.529632,"marketCap":1644752286},{"date":"2024-06-14","current":-15.80323,"twenty":-27.555589,"median":-10.757467,"eighty":-6.535093,"marketCap":1672771916},{"date":"2024-06-21","current":-14.832624,"twenty":-27.515003,"median":-10.872006,"eighty":-6.544597,"marketCap":1570033273},{"date":"2024-06-28","current":-15.441459,"twenty":-27.497599,"median":-10.886941,"eighty":-6.546992,"marketCap":1634478422},{"date":"2024-07-05","current":-16.129707,"twenty":-27.46857,"median":-10.895132,"eighty":-6.547068,"marketCap":1707329460},{"date":"2024-07-12","current":-19.703302,"twenty":-27.433901,"median":-10.971954,"eighty":-6.563648,"marketCap":2085594467},{"date":"2024-07-15","current":-19.782715,"twenty":-27.390034,"median":-10.980237,"eighty":-6.575001,"marketCap":2094000356},{"date":"2024-08-02","current":-14.779682,"twenty":-27.346167,"median":-10.988519,"eighty":-6.586355,"marketCap":1564429347},{"date":"2024-08-09","current":-13.10148,"twenty":-27.118416,"median":-11.028144,"eighty":-6.628449,"marketCap":1518173342},{"date":"2024-08-16","current":-15.270224,"twenty":-26.968782,"median":-11.081906,"eighty":-6.645077,"marketCap":1769483074},{"date":"2024-08-23","current":-15.852872,"twenty":-26.922811,"median":-11.128599,"eighty":-6.653522,"marketCap":1836999121},{"date":"2024-08-30","current":-14.90607,"twenty":-26.774081,"median":-11.15454,"eighty":-6.687148,"marketCap":1727285544},{"date":"2024-09-06","current":-14.137298,"twenty":-26.625351,"median":-11.175293,"eighty":-6.73827,"marketCap":1638201871},{"date":"2024-09-13","current":-14.218222,"twenty":-26.573972,"median":-11.217761,"eighty":-6.7713,"marketCap":1647579100},{"date":"2024-09-20","current":-23.87237,"twenty":-26.530705,"median":-11.26868,"eighty":-6.836577,"marketCap":2766282496},{"date":"2024-09-27","current":-21.031963,"twenty":-26.4631,"median":-11.317697,"eighty":-6.856316,"marketCap":2437141765},{"date":"2024-10-04","current":-21.549872,"twenty":-26.336004,"median":-11.344973,"eighty":-6.919376,"marketCap":2497156029},{"date":"2024-10-11","current":-24.268894,"twenty":-26.202441,"median":-11.368102,"eighty":-6.922342,"marketCap":2812230917},{"date":"2024-10-18","current":-28.73586,"twenty":-26.4631,"median":-11.408961,"eighty":-6.92798,"marketCap":3329853946},{"date":"2024-10-25","current":-28.015642,"twenty":-26.684508,"median":-11.434907,"eighty":-6.952885,"marketCap":3246396610},{"date":"2024-10-31","current":-26.96364,"twenty":-26.96364,"median":-11.513563,"eighty":-7.042672,"marketCap":3124492636},{"date":"2024-11-08","current":-26.729787,"twenty":-27.433901,"median":-11.673324,"eighty":-7.080084,"marketCap":3322352163},{"date":"2024-11-15","current":-25.040722,"twenty":-27.433901,"median":-11.88644,"eighty":-7.095836,"marketCap":3112411553},{"date":"2024-11-22","current":-24.362711,"twenty":-27.214567,"median":-11.987002,"eighty":-7.10489,"marketCap":3028138773},{"date":"2024-11-29","current":-25.139758,"twenty":-27.022265,"median":-11.99671,"eighty":-7.112719,"marketCap":3124721061},{"date":"2024-12-06","current":-24.050368,"twenty":-26.96575,"median":-12.085114,"eighty":-7.12231,"marketCap":2989316481},{"date":"2024-12-13","current":-21.444975,"twenty":-26.961263,"median":-12.432055,"eighty":-7.124413,"marketCap":2665481753},{"date":"2024-12-20","current":-23.463774,"twenty":-26.923955,"median":-12.541919,"eighty":-7.126371,"marketCap":2916406323},{"date":"2024-12-27","current":-22.59531,"twenty":-26.885525,"median":-12.831037,"eighty":-7.129528,"marketCap":2808461414},{"date":"2025-01-03","current":-20.591747,"twenty":-26.845911,"median":-12.998725,"eighty":-7.132489,"marketCap":2559430614},{"date":"2025-01-10","current":-19.365232,"twenty":-26.798551,"median":-13.061668,"eighty":-7.13838,"marketCap":2406982102},{"date":"2025-01-17","current":-20.355586,"twenty":-26.723148,"median":-13.311881,"eighty":-7.158703,"marketCap":2530077174},{"date":"2025-01-24","current":-20.568893,"twenty":-26.696593,"median":-13.530701,"eighty":-7.17389,"marketCap":2556589959},{"date":"2025-01-31","current":-21.330704,"twenty":-26.636168,"median":-13.63962,"eighty":-7.20167,"marketCap":2651278476},{"date":"2025-02-07","current":-21.856353,"twenty":-26.582084,"median":-13.797421,"eighty":-7.211023,"marketCap":2716613552},{"date":"2025-02-14","current":-19.822318,"twenty":-26.541522,"median":-13.871063,"eighty":-7.222326,"marketCap":2463795212},{"date":"2025-02-21","current":-20.645074,"twenty":-26.498255,"median":-13.993737,"eighty":-7.223314,"marketCap":2566058810},{"date":"2025-02-28","current":-20.104188,"twenty":-26.390088,"median":-14.063376,"eighty":-7.238231,"marketCap":2498829963},{"date":"2025-03-07","current":-20.013934,"twenty":-26.246766,"median":-14.178715,"eighty":-7.269574,"marketCap":2678124610},{"date":"2025-03-14","current":-17.986216,"twenty":-26.158706,"median":-14.218222,"eighty":-7.277624,"marketCap":2406789554},{"date":"2025-03-21","current":-16.947455,"twenty":-26.007741,"median":-14.307615,"eighty":-7.303904,"marketCap":2267789841},{"date":"2025-03-28","current":-16.677093,"twenty":-25.8593,"median":-14.436548,"eighty":-7.36558,"marketCap":2231611833},{"date":"2025-04-04","current":-9.661899,"twenty":-25.815257,"median":-14.422491,"eighty":-7.47295,"marketCap":1292887743},{"date":"2025-04-11","current":-8.231824,"twenty":-25.787291,"median":-14.322094,"eighty":-7.521714,"marketCap":1101525124},{"date":"2025-04-17","current":-9.270585,"twenty":-25.76238,"median":-14.242499,"eighty":-7.545461,"marketCap":1240524837},{"date":"2025-04-25","current":-12.100221,"twenty":-25.689401,"median":-14.191468,"eighty":-7.561735,"marketCap":1619166810},{"date":"2025-04-29","current":-12.320225,"twenty":-25.649142,"median":-14.178715,"eighty":-7.564848,"marketCap":1648606207}],"updateTime":1746086219861}}}